Home > News > Top Stories > AXENYA MERGES WITH HEALTHCO TO CREATE THE MOST ADVANCED HEALTH-TECH ECOSYSTEM IN THE REGION

Medical Devices

AXENYA MERGES WITH HEALTHCO TO CREATE THE MOST ADVANCED HEALTH-TECH ECOSYSTEM IN THE REGION

AXENYA, a leading Latin-American digital health start-up company, and HealthCo, a premier data-intensive consulting firm and insurance broker, announce that they have reached an agreement to merge the companies into the leading corporate health-tech ecosystem in the Latin-American region.

The combined companies will serve over 35,000 lives and have the capacity to deliver value across the entire healthcare journey. The companies expect to more than double that number in the coming year. All founding and operating teams at HealthCo and Axenya will remain in the company and as shareholders of the new company, which will operate under the Axenya brand.

"The New Axenya marries the most advanced population data science with cutting edge, clinically proven, digital therapeutics", said Mariano García-Valiño, Founder of Axenya. "The combination creates an unbeatable ecosystem, where we can gather data to analyze large populations, identify care gaps and create perfectly targeted individual digital plans for each person, improving clinical metrics and reducing cost across the entire spectrum".

Axenya, that started operations in 2020, offers software and hardware products that expand the doctor's toolbox, allows them to help their patients achieve higher standards of health and make the overall practice of medicine more personalized and precise. The company is the first member of the Digital Therapeutic Alliance in Latin America and the only company in the region with clinical research published in peer-reviewed journals. HealthCo is one of the most advanced data-intensive healthcare brokers in the region and approaching 90 corporate clients. Their proprietary data analytics result in consistent savings for their client base.

The combination becomes a one stop shop to enable corporate clients to maximize quality and expense in all aspects of their healthcare needs: from population analytics, 24/7 monitoring and course correction, delivering individually selected next generation digital therapeutic tools and ultimately renegotiating fees with payors driven by the savings generated by its healthcare program. As a result, Axenya will deliver unparalleled clinical results, user satisfaction and cost savings.

"We now have a company that can deliver results like nobody else in the market. Using a combination of software, technology, machine learning and behavioral and data science, Axenya can optimize the healthcare journey end-to-end, empowering companies and its employees with unbiased information, trusted guidance and high-value care, and delivering, at the same time, effective cost savings."

Roberto Vianna, co-Founder of HealthCo

In combination with this merger, Axenya received a capital injection, led by IGAH ventures, and with participation of NXTP, Big_Bets, Alexia, Axenya's founder Mariano Garcia-Valiño and several individual investors and employees.

ABOUT AXENYA
Axenya is a health technology company that seeks to connect Latin America with the future of medicine. With its digitally enhanced corporate health ecosystem, it offers and manages the most suitable healthcare plans in a digital, efficient and transparent fashion, protecting the employee's health, end to end, through all the journey. Integrating cutting edge software, hardware, artificial intelligence, intensive data-analysis and behavioral sciences, Axenya improves the efficiency in delivering health services, as well as expands the companies' toolbox and makes medicine more personal and precise, offering what is effectively a new care standard. The company delivers excellent patient satisfaction, superior clinic results and lower costs, improving the quality per dollar spent by companies while allowing access to modern medicine to all employees and dependents.

Spotlight

More featured news

Spotlight

Related News

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Healthcare Analytics

UnitedHealthcare's Surest Plan Boosts Prevention and Reduces Costs

UnitedHealthcare's | October 09, 2023

Surest Impact Study shows that employers can reduce healthcare expenses by up to 15%, with an average savings of 11%. UnitedHealthcare offers Surest to self-funded employers with 51+ employees in 32 states and plans to expand to six more by early 2024. Lumen Technologies, a multinational technology corporation that introduced Surest in 2020, discovered that 62% of surveyed employees attributed improved health to the plan. UnitedHealthcare's Surest health plan, which eliminates deductibles and provides transparent upfront pricing information before treatment, facilitates increased utilization of preventive care services by members while concurrently decreasing their out-of-pocket expenses. The new Surest Impact Study shows that people are more involved with their health plans than regular ones. Surest is designed to make it easier for people to get medical care and not wait or skip important checkups and treatments that could save lives. They achieve this by eliminating deductibles and providing transparent cost information in advance of scheduling appointments. Dan Kueter, CEO of UnitedHealthcare's commercial business, said, We know people want a health plan that's simple, easy to use and helps them select the right care at the right time and in the right setting." He added, "We're pleased to see that Surest's innovative plan design, including an intuitive digital experience, is resonating with members and employers. [Source – Business Wire] Surest has become the most rapidly growing plan in UnitedHealthcare's commercial portfolio, with hundreds of employers, a combined workforce of over 4.4 million employees, while 1 in 6 of the company's national account clients opting for it as an option for 2024. The latest Surest Impact Study reveals several noteworthy findings. As per the study, Surest members exhibited a substantial increase in preventive care utilization, with a 20% rise in physician visits and a 9% boost in preventive physical exams compared to those enrolled in conventional plans. Particularly impressive were the 15% improvement in preventive mammograms and a remarkable 34% higher rate of preventive colonoscopies among Surest members, facilitating earlier identification of potential health issues and potentially leading to better health outcomes and improved quality of life. Moreover, Surest demonstrated its cost-effectiveness, as members experienced a 54% reduction in out-of-pocket expenses, while employers reported an average savings of 11%. This was accomplished partly through a 13% reduction in inpatient hospital admissions and a 6% decrease in emergency room visits, significantly contributing to employers' costs. Surest members preferred higher-value care settings, with a 6% higher rate of urgent care utilization and a remarkable 7-fold increase in virtual care visits. Furthermore, member satisfaction with Surest plans was notably high, as reflected in the Net Promoter Score, which exceeded industry benchmarks. Impressively, 9 out of 10 Surest members chose to re-enroll in the health plan year after year, underscoring their satisfaction with the program.

Health Technology

GE HealthCare and Mass General Brigham Unite for AI Care Insights

GE HealthCare | September 08, 2023

Leveraging operational AI and ML has the potential to unite providers and optimize the consolidation of data sets. During initial testing, the AI-driven algorithm demonstrated the ability to accurately forecast missed care opportunities, with success rates as high as 96%. AI and machine learning insights strategically improve productivity and administrative efficiency at both departmental and enterprise levels. In 2017, GE HealthCare and Mass General Brigham embarked on a ten-year partnership focused on AI innovation in diagnostics and treatments. GE HealthCare and Mass General Brigham have unveiled the joint development of an AI algorithm. This algorithm is designed to enhance operational efficiency and productivity in healthcare. The maiden AI application stemming from this collaboration is the 'schedule predictions dashboard' integrated into the Radiology Operations Module (ROM), a digital imaging tool readily available for deployment by healthcare institutions. Its primary objective encompasses the optimization of scheduling procedures, cost reduction, and alleviating administrative burdens placed on healthcare providers. By doing so, ROM liberates valuable time, permitting clinicians to invest more of their efforts into fostering and strengthening the clinician-patient relationship. Amid a vast sea of data and the demanding responsibilities that often divert healthcare providers from patient care, Parminder Bhatia, Chief AI Officer of GE HealthCare, described the collaboration with Mass General Brigham as groundbreaking. He added that they combine unique datasets and utilize cutting-edge machine learning techniques, harnessing the synergy of clinical and technical expertise to usher in unprecedented advancements in healthcare. Keith Dreyer, DO, Ph.D., Chief Data Science Officer, Mass General Brigham, remarked, This technology has the potential to reduce burnout and allow physicians to spend more time with patients, which may ultimately lead to better outcomes. [Source: Business Wire] Operational AI-enabled tools can tackle challenges that frequently jeopardize patient care, including the cost of healthcare and inefficiencies within hospitals. When a patient misses an appointment, neglects to schedule a follow-up, or arrives late, collectively called missed care opportunities (MCO), the repercussions can be substantial. The algorithm developed in collaboration is designed to forecast MCO and late arrivals. This initiative aims to enhance operational flexibility, streamline administrative processes, elevate patient satisfaction, and more effectively accommodate urgent, inpatient, or walk-in appointments. GE HealthCare, a global leader in medical technology, pharmaceutical diagnostics, and digital solutions, focuses on delivering integrated solutions, services, and data analytics to enhance hospital efficiency, support clinicians, improve therapy precision, and promote patient well-being. With over a century of service to patients and healthcare providers, the company advances personalized, connected, and compassionate care through imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics.